Matsuda Masaru's Form 4 filing
Arcutis Biotherapeutics, Inc. (ARQT) · filed May 6, 2026
- Accession no.
- 0001798679-26-000002
- Filed
- May 6, 2026
- Trade date
- May 4, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $192.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Matsuda MasaruCIK 0001798679 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | SSaleDisposed | −7,372 | $23.27 | −$171,546.44 | 127,573 | Direct | |
| May 4, 2026 | Common Stock | SSaleDisposed | −884 | $23.61 | −$20,871.24 | 126,689 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.